DANISH BIO – DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately four "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

News

Y-mAbs Announces Second Quarter 2020 Financial Results and Recent Corporate Developments 06 August 2020

Y-mAbs Therapeutics, Inc., a late-stage clinical biopharmaceutical company focused on the development... Read more

Y-mAbs Announces Completion of Submission of Omburtamab Biologics License Application to FDA 06 August 2020

Y-mAbs Therapeutics, Inc., a late-stage clinical biopharmaceutical company focused on the development... Read more

Commercializing products in the U.S. marketplace – Educational Web Series 09 July 2020

Are you a start-up and early-stage MedTech company interested in commercializing your pro... Read more

Unilabs launches large-scale Covid-19 immunity study with Greater Copenhagen hospitals 01 July 2020

Unilabs Denmark, a unit of the leading European diagnostic services provider, has launched a larg... Read more

Y-mAbs Announces Initiation of Submission of Omburtamab Rolling Biologics License Application to the FDA 30 June 2020

Y-mAbs Therapeutics, Inc., a late-stage clinical biopharmaceutical company focused on the develop... Read more

Free book download for our members: Assembled Chaos: Accelerate your medical research career while changing the future of medicine… 30 June 2020

As you probably realise consortia are becoming an increasingly common way to conduct medical research... Read more

Dansk Standard: Invitation to participation in development of the future Biotech standards 10 June 2020

Are you interested in being part of developing the future Biotech standards ?Read more

Y-mAbs Announces U.S. FDA Acceptance of Biologics License Application for Danyelza™ (naxitamab) for the Treatment of Neuroblastoma for Priority Review 08 June 2020

Y-mAbs Therapeutics, Inc., a late-stage clinical biopharmaceutical company focused on the develop... Read more

Y-mAbs Announces Data to be Presented at 2020 ASCO Annual Meeting 13 May 2020

Y-mAbs Therapeutics, Inc., a late-stage clinical biopharmaceutical company focused on the development... Read more

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact ps@danskbiotek.dk or +45 7172 1114
About Us
DANISH BIO – DANSK BIOTEK
COBIS
Ole Maaløes Vej 3
2200 Copenhagen N
e-mail: ps@danskbiotek.dk
office@danskbiotek.dk
tlf: +45 7172 1114
Privacy Policy / Cookies
Copyright 2020 DANISH BIO – DANSK BIOTEK. All rights reserved.
created by: Mastafu Design